Patents by Inventor Eliot Ohlstein

Eliot Ohlstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF A PPAR-DELTA AGONIST FOR REDUCING LOSS OF MUSCLE STRENGTH, MUSCLE MASS, OR TYPE I MUSCLE FIBERS IN AN IMMOBILIZED LIMB
    Publication number: 20170027950
    Abstract: The present invention provides methods for reducing loss of muscle strength, muscle mass, or Type I muscle fibers in an immobilized limb by administering (E)-[4-[3-(4-Fluorophenyl)-3-[4-[3-(morpholin-4-yl)propynyl]phenyl]allyloxy]-2-methyl-phenoxy]acetic acid or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: October 6, 2016
    Publication date: February 2, 2017
    Inventors: Maria Carmen Valcarce Lopez, Eliot Ohlstein
  • Pharmaceutical Combination
    Patent number: 9522129
    Abstract: Pharmaceutical combinations comprising a beta-3 adrenergic receptor agonist and a muscarinic receptor antagonist, and methods for their use are disclosed. Methods of using the pharmaceutical combinations for the treatment of one or more symptoms associated with overactive bladder, for example, frequency of urgency, nocturia, and urinary incontinence, are also disclosed.
    Type: Grant
    Filed: February 8, 2013
    Date of Patent: December 20, 2016
    Assignee: Velicept Therapeutics, Inc.
    Inventors: Stephen Caltabiano, Eliot Ohlstein, Stewart McCallum
  • Use of a PPAR-delta agonist for treating muscle atrophy
    Patent number: 9487493
    Abstract: The present invention provides methods for treating muscle atrophy by administering a PPAR? agonist.
    Type: Grant
    Filed: September 5, 2014
    Date of Patent: November 8, 2016
    Assignee: vTv Therapeutics LLC
    Inventors: Maria Carmen Valcarce Lopez, Eliot Ohlstein
  • COMPOSITIONS AND METHODS OF USING MODIFIED RELEASE SOLABEGRON FOR LOWER URINARY TRACT SYMPTOMS
    Publication number: 20160158176
    Abstract: This application relates to pharmaceutical compositions, comprising solabegron that are useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to methods for treating lower urinary tract symptoms utilizing the pharmaceutical compositions, comprising solabegron. In some embodiments, the pharmaceutical compositions, comprising solabegron comprise a dual release drug delivery system.
    Type: Application
    Filed: December 3, 2015
    Publication date: June 9, 2016
    Inventors: Eliot OHLSTEIN, Raymond E. STEVENS, JR., H. Jeffrey WILKINS
  • USE OF A PPAR-DELTA AGONIST FOR TREATING MUSCLE ATROPHY
    Publication number: 20150072985
    Abstract: The present invention provides methods for treating muscle atrophy by administering a PPAR? agonist.
    Type: Application
    Filed: September 5, 2014
    Publication date: March 12, 2015
    Inventors: Maria Carmen Valcarce Lopez, Eliot Ohlstein
  • Pharmaceutical combinations of beta-3 adrenergic receptor agonists and muscarinic receptor antagonists
    Patent number: 8642661
    Abstract: Pharmaceutical combinations comprising a beta-3 adrenergic receptor agonist and a muscarinic receptor antagonist, and methods for their use are disclosed. Disclosed combinations include solabegron and oxybutynin. Methods of using the pharmaceutical combinations for the treatment of one or more symptoms associated with overactive bladder, for example, frequency of urgency, nocturia, and urinary incontinence, are also disclosed.
    Type: Grant
    Filed: August 2, 2011
    Date of Patent: February 4, 2014
    Assignee: Altherx, Inc.
    Inventors: Stephen Caltabiano, Eliot Ohlstein, Stewart McCallum
  • PHARMACEUTICAL COMBINATIONS
    Publication number: 20120035118
    Abstract: Pharmaceutical combinations comprising a beta-3 adrenergic receptor agonist and a muscarinic receptor antagonist, and methods for their use are disclosed. Disclosed combinations include solabegron and oxybutynin. Methods of using the pharmaceutical combinations for the treatment of one or more symptoms associated with overactive bladder, for example, frequency of urgency, nocturia, and urinary incontinence, are also disclosed.
    Type: Application
    Filed: August 2, 2011
    Publication date: February 9, 2012
    Applicant: ALTHERX, INC.
    Inventors: Stephen Caltabiano, Eliot Ohlstein, Stewart McCallum
  • Method of Treating Isolated Systolic Hypertension
    Publication number: 20070129415
    Abstract: This invention relates to the use of eprosartan to treat isolated systolic hypertension.
    Type: Application
    Filed: February 12, 2007
    Publication date: June 7, 2007
    Inventors: David BROOKS, Giora Feuerstein, Eliot Ohlstein, Robert Ruffolo
  • Method of treating isolated systolic hypertension
    Publication number: 20050113431
    Abstract: This invention relates to the use of eprosartan to treat isolated systolic hypertension.
    Type: Application
    Filed: December 14, 2004
    Publication date: May 26, 2005
    Inventors: David Brooks, Giora Feuerstein, Eliot Ohlstein, Robert Ruffolo